Protagonist Therapeutics Inc (PTGX)
Capital Expenditure
$975.00K
TTM · Period ending: · USD
PTGX Capital Expenditure
Latest reported$975.00Kperiod ending
Latest reported$975.00Kperiod ending
PTGX TTM CapEx (-$399.00K → $975.00K)
TTM CapEx
High-resolution chart · PNG
PTGX capital expenditure history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Capital Expenditure (USD) |
|---|---|
| 975,000 | |
| 330,000 | |
| 0 | |
| -1,756,000 | |
| -2,443,000 | |
| -1,658,000 | |
| -1,355,000 | |
| -1,064,000 | |
| -693,000 | |
| -841,000 | |
| -609,000 | |
| -660,000 | |
| -418,000 | |
| -532,000 | |
| -795,000 | |
| -921,000 | |
| -1,024,000 | |
| -1,234,000 | |
| -1,101,000 | |
| -1,030,000 | |
| -840,000 | |
| -473,000 | |
| -471,000 | |
| -564,000 | |
| -180,000 | |
| -939,000 | |
| -967,000 | |
| -811,000 | |
| -1,268,000 | |
| -444,000 | |
| -486,000 | |
| -480,000 | |
| -522,000 | |
| -826,000 | |
| -666,000 | |
| -662,000 | |
| -520,000 | |
| -176,000 | |
| -379,000 | |
| -547,000 | |
| -612,000 | |
| -645,000 | |
| -399,000 |